NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,306,516 | -0.4% | 22,644 | -1.4% | 2.07% | +4.3% |
| Q2 2023 | $2,316,287 | +7.3% | 22,954 | -2.2% | 1.99% | +1.1% |
| Q1 2023 | $2,159,332 | +3.1% | 23,471 | +1.7% | 1.96% | -3.9% |
| Q4 2022 | $2,094,090 | +18.6% | 23,083 | -0.6% | 2.04% | +8.7% |
| Q3 2022 | $1,765,000 | -11.0% | 23,221 | -1.0% | 1.88% | -5.7% |
| Q2 2022 | $1,984,000 | -5.4% | 23,461 | -1.8% | 1.99% | +30.1% |
| Q1 2022 | $2,097,000 | -6.3% | 23,893 | -6.6% | 1.53% | +1.5% |
| Q4 2021 | $2,237,000 | +10.7% | 25,586 | +3.6% | 1.51% | -4.7% |
| Q3 2021 | $2,020,000 | -10.9% | 24,706 | -0.6% | 1.58% | -17.1% |
| Q2 2021 | $2,267,000 | +0.1% | 24,846 | -6.2% | 1.91% | -4.5% |
| Q1 2021 | $2,264,000 | -10.4% | 26,481 | -1.0% | 2.00% | -13.8% |
| Q4 2020 | $2,528,000 | +10.2% | 26,755 | +1.4% | 2.32% | -0.3% |
| Q3 2020 | $2,295,000 | +1.5% | 26,390 | +1.9% | 2.33% | -7.8% |
| Q2 2020 | $2,262,000 | +6.8% | 25,905 | +0.8% | 2.53% | -11.3% |
| Q1 2020 | $2,118,000 | -10.6% | 25,710 | +2.8% | 2.85% | +8.7% |
| Q4 2019 | $2,368,000 | +10.2% | 25,015 | +1.2% | 2.62% | +0.8% |
| Q3 2019 | $2,149,000 | -9.6% | 24,723 | -5.1% | 2.60% | -4.7% |
| Q2 2019 | $2,378,000 | -4.3% | 26,052 | +0.8% | 2.73% | -7.0% |
| Q1 2019 | $2,486,000 | +14.8% | 25,847 | +2.4% | 2.93% | -2.5% |
| Q4 2018 | $2,165,000 | -1.7% | 25,232 | -1.3% | 3.01% | +21.9% |
| Q3 2018 | $2,203,000 | +16.8% | 25,560 | +2.4% | 2.47% | +7.0% |
| Q2 2018 | $1,886,000 | -2.1% | 24,952 | +4.8% | 2.31% | -2.9% |
| Q1 2018 | $1,926,000 | -3.1% | 23,814 | +0.6% | 2.38% | -0.9% |
| Q4 2017 | $1,987,000 | +30.6% | 23,679 | +33.8% | 2.40% | +11.9% |
| Q3 2017 | $1,521,000 | +10.8% | 17,696 | +7.6% | 2.14% | +8.8% |
| Q2 2017 | $1,373,000 | +19.7% | 16,452 | +6.5% | 1.97% | +12.1% |
| Q1 2017 | $1,147,000 | +8.0% | 15,447 | +5.9% | 1.76% | -5.6% |
| Q4 2016 | $1,062,000 | -12.7% | 14,584 | -5.2% | 1.86% | -12.6% |
| Q3 2016 | $1,216,000 | -3.0% | 15,389 | +1.3% | 2.13% | -4.6% |
| Q2 2016 | $1,253,000 | +16.9% | 15,185 | +2.6% | 2.23% | +18.7% |
| Q1 2016 | $1,072,000 | -3.7% | 14,806 | +14.5% | 1.88% | -12.2% |
| Q4 2015 | $1,113,000 | – | 12,936 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |